Boehringer pays up to $250M to expand Variant Bio’s pact into heart disease

Why it matters: The German drugmaker is extending its search for genetically supported drug targets in an area central to its business. Boehringer already markets Jardiance for heart failure and chronic kidney disease and is testing its combination with vicadrostat in Phase 3 studies.

SupplySide Global 2026: Concordix debuts chewable postbiotics for beauty and immunity

Concordix by Vitux will showcase its patented, chewable emulsion matrix in three new postbiotic concepts supporting beauty-from-within, immune health, and the gut microbiome at the upcoming SupplySide Global 2026 trade fair in Las Vegas, Nevada, US (Oct 26–30). 

Basecamp Research raises $140M for AI-designed cell therapies

Why it matters: Basecamp wants to use AI to design both genetic payloads and the proteins that insert them into cells. If it can make that work in vivo, the approach could avoid some of the manufacturing steps required to produce conventional CAR-T therapies.

Unilever sharpens global brand focus with Zwitsal sale

Unilever has received a binding offer from Dutch personal care manufacturer Royal Sanders for baby care brand Zwitsal. The move is part of the consumer goods giant’s strategy of concentrating its portfolio on its largest international brands and priority categories.

Pinggu Consensus: China Bets on AI & Policy Coordination to Transform the Future of Food

China has taken another big leap in its bid to lead the future food race, with government officials publishing consensus points to deliver a “green and healthy transformation of agrifood systems” with the help of artificial intelligence (AI).

Now Part of Refresco, SunOpta Opens $35M Production Line for Plant-Based Dairy

US food producer SunOpta, known for its non-dairy milk and creamer brands Sown, West Dream and West Life, is aiming to meet increased consumer demand with a new production line at its Midlothian, Texas facility.

Virtual fencing is no longer hype. Now it has to prove itself a trustworthy tool

News of Halter’s $220 million Series E earlier this year—a round that valued the New Zealand livestock technology compan…

Target deepens K-wellness offering with Clöud Café holiday launch

K-wellness brand Clöud Café is deepening its Target partnership with a limited-edition holiday collection launching online and in-store endcaps.

Biomimetic Nanoparticles Trigger Light Responses in Blind Mouse Retinas

Even after a retina loses its natural light-sensing cells, some of its nerve circuitry can remain intact. In a new preclinical study, researchers showed that injectable, light-sensitive nanoparticles can lodge near surviving retinal nerve cells and help degenerated mouse retinas respond to illumination.

ViferaXS secures up to €12M for leukemia trial

Why it matters: The trial will test whether an immune response seen in a small Phase 1 study translates into a clinical benefit for patients.